Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy

Japanese Journal of Clinical Oncology

Volumn 43, Issue 7, 2013, Pages 719-725

  Goto, Yoko ^a,b   Kodaira, Takeshi ^a   Furutani, Kazuhisa ^a   Tachibana, Hiroyuki ^a   Tomita, Natsuo ^a   Ito, Junji ^a   Hanai, Nobuhiro ^a   Ozawa, Taijiro ^a   Hirakawa, Hitoshi ^a   Suzuki, Hidenori ^a   Hasegawa, Yasuhisa ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Limited field; Postoperative radiotherapy; Squamous cell carcinoma of the head and neck

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX; LARYNX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH CAVITY; OROPHARYNX; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION FIELD; SURVIVAL RATE;

LIMITED FIELD; POSTOPERATIVE RADIOTHERAPY; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS;

EID: 84880169232     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt066     Document Type: Article

References (19)

1. Bartelink H, Breur K, Hart G, Annyas B, van Slooten E, Snow G. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer 1983;52:1008-13.
2. Vikram B, Strong EW, Shah JP, Spiro R. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-3.
3. Vikram B, Strong EW, Shah JP, Spiro R. Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:724-9.
4. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
5. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571-8.
6. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52.
7. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
8. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:475-81.
9. Fletcher GH, Evers WT. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology 1970;95:185-8.
10. Huang DT, Johnson CR, Schmidt-Ullrich R, Grimes M. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive resection margins: a comparative study. Int J Radiat Oncol Biol Phys 1992;23:737-42.
11. Frank JL, Garb JL, Kay S, et al. Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg 1994;168:476-80.
12. Nisi KW, Foote RL, Bonner JA, McCaffrey TV. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys 1998;41:371-7.
13. Olsen KD, Caruso M, Foote RL, et al. Primary head and neck-cancer-histopathologic predictors of recurrence after neck dissection in patients with lymph-node involvement. Arch Otolaryngol Head Neck Surg 1994;120:1370-4.
14. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys 1997;39:137-48.
15. Muriel VP, Tejada MR, de Dios Luna del Castillo J. Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas. Radiother Oncol 2001;60:137-45.
16. Jonkman A, Kaanders JH, Terhaard CH, et al. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:119-25.
17. Leon X, Lopez M, Pineiro Z, Langendijk JA, Leemans CR, Quer M. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck 2007;29:815-21.
18. Langendijk JA, Slotman BJ, van der Waal I, Doornaert P, Berkof J, Leemans CR. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Cancer 2005;104: 1408-17.
19. Winquist E, Oliver T, Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Head Neck 2007;29:38-46.